US › Healthcare

Guardant Health Inc (GH)

US · Healthcare · Diagnostics & Research

$159.79+0.60%
Last close · 2026-08-04

Latest quarter · ended 2026-06-30

Revenue
$335.0M
Revenue YoY
+44.3%
Net profit
$-120.1M
Profit YoY
-20.3%
EPS
$-0.89
EPS estimate
$-0.74
Net margin
-35.9%

EPS came in at -0.89 against a street estimate of -0.74 — a miss of 20.3%.

Key statistics

Market cap
$21.31B
Forward P/E
0.0
P/B
55.67
Book value
$-1.38
EPS (TTM)
$-3.52
52-week high
$176.58
52-week low
$43.66
50-day MA
$142.11
200-day MA
$107.31
Beta
1.59

Analyst view

Analysts rate Guardant Health Inc a strong buy (22 buy, 0 hold, 1 sell out of 23) with an average price target of $187.50.

Shareholding

Insiders
3.97%
Institutions
103.34%

Largest institutional holders

FundStake
BlackRock Inc8.61%
T. Rowe Price Associates, Inc.5.23%
Vanguard Portfolio Management, LLC4.35%
Vanguard Capital Management, LLC4.19%
Amvescap Plc.3.69%
The Goldman Sachs Group Inc3.31%
Two Sigma Investments LLC3.15%
FMR Inc3.07%

Recent filings & reports

DocumentDate
Quarterly report · Q2 20262026-07-30
Results announced · Q3 20262026-07-30
Shareholder vote results · Q2 20262026-06-18
Quarterly report · Q1 20262026-05-07
Results announced · Q2 20262026-05-07
Proxy statement · Q2 20262026-04-28
Board / officer change · Q2 20262026-04-27
Annual report FY20252026-02-19

Readable in the app.

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Guardant Health Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.